BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Janssen Biotech Inc. 

800 Ridgeview Drive

Horsham  Pennsylvania  19044  U.S.A.
Phone: 888-227-5624 Fax: n/a


SEARCH JOBS










 Company News
Genmab A/S (GEN.CO) Reaches $22 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 3/27/2014 7:25:31 AM    More...
Amunix, Inc. Announces Expansion To Licensing Agreement With Janssen Biotech Inc. (JNJ) For Its Proprietary XTEN Technology 1/7/2014 9:44:17 AM    More...
Little Biotech, Capricor Therapeutics, Inc. Inks Heart Pact Worth $337.5 Million With Johnson & Johnson (JNJ)'s Janssen Biotech Inc. (JNJ) 1/6/2014 7:32:53 AM    More...
Genmab A/S (GEN.CO) To Receive Milestone Payment In Duobody Platform Collaboration With Janssen Biotech Inc. – Financial Guidance Improved 12/6/2013 9:10:02 AM    More...
Genmab A/S (GEN.CO) Announces Expansion Of Duobody Platform Collaboration With Janssen Biotech Inc. 12/4/2013 9:18:13 AM    More...
Genmab A/S (GEN.CO) Gets $8 Million Milestone Payment In Pact With Janssen Biotech Inc., Improves 2013 Guidance 11/26/2013 6:55:42 AM    More...
Effimune Announces Global License Agreement With Janssen Biotech Inc. 10/3/2013 8:49:34 AM    More...
Janssen Biotech Inc.'s STELARA® (ustekinumab) Receives FDA Approval to Treat Active Psoriatic Arthritis 9/23/2013 6:59:30 AM    More...
MorphoSys AG Receives Two Phase 2 Milestone Payments From Janssen Biotech Inc. 9/17/2013 9:23:54 AM    More...
Genmab A/S (GEN.CO) Reaches Milestone in DuoBody Platform Collaboration With Janssen Biotech Inc. 8/26/2013 9:38:59 AM    More...
12345678